Marina Biotech, Inc. to Present at Biotech Showcase 2011

BOTHELL, WA--(Marketwire - January 4, 2011) -  Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it will present at Biotech Showcase 2011 on Tuesday, January 11, 2011, at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time) at the Parc 55 Wyndham San Francisco Union Square in San Francisco. J. Michael French, Marina Biotech President and Chief Executive Officer, will present a corporate overview and business update. 

A live audio webcast will be available on the Event Calendar pages of the Investors section of the Company's website at http://www.marinabio.com. Please allow time prior to the presentation to register and download any necessary software. A replay of the presentation will be available on the Investors section of the Marina Biotech website under Event Calendar approximately one and a half hours after the live presentation.

About Marina Biotech, Inc.

Marina Biotech is a biotechnology company, focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). The Marina Biotech pipeline currently includes a clinical program in Familial Adenomatous Polyposis (a precancerous syndrome) and two preclinical programs -- in hepatocellular carcinoma and bladder cancer. Marina Biotech's goal is to improve human health through the development of RNAi-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Additional information about Marina Biotech is available at http://www.marinabio.com.

Contact Information:

Contact:
Marina Biotech, Inc.:
Pete Garcia
Chief Financial Officer
(425) 908-3603